Select Medical
SEM was delisted on the 30th of June, 2026.
278 hedge funds and large institutions have $1.6B invested in Select Medical in 2026 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 88 increasing their positions, 87 reducing their positions, and 47 closing their positions.
30% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 47
7% more capital invested
Capital invested by funds: $1.49B → $1.6B (+$105M)
4% more funds holding
Funds holding: 268 → 278 (+10)
1% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 87
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.04% less ownership
Funds ownership: 81.06% → 79.02% (-2%)
100% less call options, than puts
Call options by funds: $8K | Put options by funds: $1.69M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$77.6M |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$63.8M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
+$34.7M |
| 4 |
SFM
Soros Fund Management
New York
|
+$28.7M |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$28.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$257M |
| 2 |
WSL
Western Standard LLC
Los Angeles,
California
|
-$30.7M |
| 3 |
BlackRock
New York
|
-$22.5M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$18.8M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$15.4M |
SEM Hedge Fund Activity: Q1 2026 in Review
278 of the 8,207 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q1 2026, worth a combined $1.6B — up 7.1% from $1.49B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new SEM positions and 47 closed out — a net gain of 14 holders — while 88 added to existing stakes and 87 trimmed.
The largest buyer was Fidelity International, opening a new position worth an estimated $77.6M. The largest seller was T. Rowe Price Associates, cutting an estimated $257M.
- 278 institutional investors held Select Medical (SEM) as of Q1 2026, up from 268 in Q4 2025.
- Funds reported $1.6B of Select Medical stock for Q1 2026, up 7.1% quarter-over-quarter.
- 61 funds opened new Select Medical positions in Q1 2026 and 47 closed out, a net change of +14 holders.
- The largest Select Medical buyer in Q1 2026 was Fidelity International, an estimated $77.6M added.
- The largest Select Medical seller in Q1 2026 was T. Rowe Price Associates, an estimated $257M sold.
Based on aggregated 13F filings for Q1 2026.